期刊文献+

多位点酶切联合SSCP方法检测结核杆菌inhA基因突变 被引量:2

Detecting InhA Genetic Mutations in Mycobacterium Tuberculosis Isolates by Combining Single-strand Conformation Polymorphism Analysis with Restriction Endonuclease
下载PDF
导出
摘要 目的 建立一种简便而有效的方法检测结核分枝杆菌异烟肼耐药基因inhA突变。方法 收集结核杆菌临床菌株48株,其中异烟肼敏感株25株,耐药株23株。抽提临床菌株DNA和H37Rv标准株DNA,聚合酶链反应(PCR)方法扩增inhA基因,产物纯化后用限制性内切酶Hae Ⅱ酶切,酶切片段用单链多态构象分析(SS-CP)方法检测其单链构象。发现单链构象改变的PCR产物进行DNA测序。结果 48株菌株中,25株敏感株中未见inhA基因单链构象差异,23株耐药株中inhA基因突变率为21.8%。新发现的错义突变有:A26E、R27K、V28A、Q32A、L54V和S72T。结论 应用限制性内切酶Hae Ⅱ改良的聚合酶链反应—单链多态构象分析(PCR—SSCP)技术适用于结核临床菌株inhA基因突变的筛选。inhA基因突变位点呈多样性。 Purpose: To detect inhA genetic mutations in Mycobacterium tuberculosis (MTB) isolates, therefore to get full mutation information. Methods: A total of 48 isolates of M. tuberculosis, including 23 drug-resistant MTB isolates were collected. Their genome DNA were extracted, the targets gene were gained by PCR, the products were purified and digested with restriction endonuclease Hae II Single-strand conformation polymorphism (SSCP) method was used to detect mutations in these isolates. DNA analysis was used to identify mutant sequences when conformation change was found. Results: No inhA mutation has been identified in isoniazid-susceptible isolates while conformation changes were found in five isoniazid-resistant isolates. The mutation rate was 21.8% in isonoazid-resistant isolates. New missense mutation included A26E, R27K, V28A, Q32A, L54V and S72T. Conclusions: PCR-SSCP digesting with restriction endonudease Hae II technique is available for detecting inhA genetic mutations in MTB isolates. It also proves that mutations of inhA gene are diversiform.
出处 《复旦学报(医学版)》 EI CAS CSCD 北大核心 2004年第1期39-41,共3页 Fudan University Journal of Medical Sciences
基金 "十五"攻关基金(2001BA705B03)
关键词 多位点酶切 SSCP 联合检测 结核杆菌 inhA基因 基因突变 耐药基因 异烟肼 Conformations DNA Enzymes Genes Mutagenesis Purification
  • 相关文献

参考文献2

二级参考文献1

  • 1Kapur V,Arch Pathol Lab Med,1995年,119卷,131页 被引量:1

共引文献1

同被引文献23

  • 1赵锦荣,白玉杰,王琰,张庆华,罗明,闫小君.高通量测定技术检测结核分枝杆菌耐利福平的研究[J].中华结核和呼吸杂志,2005,28(5):297-300. 被引量:5
  • 2WHO global report on antituberculosis drug resistance: Eastern Europe and Central Asia key areas[S]. Eurosurveillance, 2004, 8 (12) : 2419. 被引量:1
  • 3Herrara L, Valverde A, Saiz P, et al. Molecular characterization of isoniazid-resistant mycobacterium tuberculosis clinical strains isolated in the Philippines[J]. Int J Antimicrob Agents, 2004, 23(6): 572-576. 被引量:1
  • 4Basso LA,Zhang R,Musser JM,et al. Mechanisms of isoniazid resistance in Mycobaeterium tuberculosis: enzymatic characterization of enoyl reductase mutants identified in isoniazid-resistant clinical isolates[J]. J Infect Dis, 1998,178(3) : 769-775. 被引量:1
  • 5Cardoso RF,Cooksey RC, Morlock GP, et al. Screening and characterization of mutations in isoniazid-resistant Mycobacterum tu bereulosis isolates obtained in Brazil[J]. Antimicrob Agents Chemother,2004,48(9):3373-3381. 被引量:1
  • 6Dhandayuthapani S, Zhang Y, Mudd MH, et al. Oxidative stress response and its role in sensitivity to isoniazid in mycobacteria: characterization and inducibility of ahpC by peroxides in Mycobacterium smegmatis and lack of expression in M. aururn and M. tubereulosis[J]. J Bacteriol, 1996,178(12) : 3641-3649. 被引量:1
  • 7Ramaswamy SV, Reich R, Dou SJ, et al. Single nucleotide polymorphisms in genes associated with isoniazid resistance in Mycobacterium tuberculosis[J]. Antimicrob Agents Chemother, 2003, 47(4): 1241-1250. 被引量:1
  • 8Taniguchi H. Molecular mechanisms of multidrug resistance in Mycobacterium tuberculosis[J]. J Uoch, 2000, 22(3) : 269-282. 被引量:1
  • 9Parsosn LM,Salfinger M,Clobridge A, et al. Phenotypic and molecular characterization of Mycobacteriumtuberculosis isolates resistant to both isoniazid and ethambutol[J]. Antimierob Agents Chemother,2005,49(6):2218-2225. 被引量:1
  • 10Riska PF, Jacobs WR Jr, Alland D. Molecular determinants of drug rsistanee in tuberculosis. Int J Tuberc Lung Dis, 2000, 4(2 Suppl 1): S4-S10. 被引量:1

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部